KalVista Pharmaceuticals, Inc. (KALV)
KALV Stock Price Chart
Explore KalVista Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze KALV price movements and trends.
KALV Company Profile
Discover essential business fundamentals and corporate details for KalVista Pharmaceuticals, Inc. (KALV) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Apr 2015
Employees
150.00
Website
https://www.kalvista.comCEO
Benjamin L. Palleiko
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include KVD001, a plasma kallikrein inhibitor that completed a Phase II clinical trial for the treatment of DME; sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; KVD824, an oral product candidate for the treatment of HAE; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.
KALV Financial Timeline
Browse a chronological timeline of KalVista Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Mar 2026
Upcoming earnings on 4 Dec 2025
EPS estimate is -$0.89.
Earnings released on 11 Sept 2025
EPS came in at -$1.12 falling short of the estimated -$0.91 by -23.08%, while revenue for the quarter reached $1.43M , missing expectations by -31.73%.
Earnings released on 10 Jul 2025
EPS came in at -$0.99 falling short of the estimated -$0.77 by -28.57%.
Earnings released on 12 Mar 2025
EPS came in at -$0.92 falling short of the estimated -$0.89 by -3.37%.
Earnings released on 5 Dec 2024
EPS came in at -$0.91 matching the estimated -$0.91.
Earnings released on 5 Sept 2024
EPS came in at -$0.87 surpassing the estimated -$0.95 by +8.42%.
Earnings released on 11 Jul 2024
EPS came in at -$1.02 falling short of the estimated -$0.71 by -43.66%, while revenue for the quarter reached $1.21M .
Earnings released on 11 Mar 2024
EPS came in at -$0.84 falling short of the estimated -$0.75 by -12.42%.
Earnings released on 7 Dec 2023
EPS came in at -$0.80 falling short of the estimated -$0.71 by -12.68%.
Earnings released on 7 Sept 2023
EPS came in at -$0.74 surpassing the estimated -$0.83 by +10.84%.
Earnings released on 7 Jul 2023
EPS came in at -$0.77 surpassing the estimated -$0.92 by +16.30%.
Earnings released on 9 Mar 2023
EPS came in at -$0.75 surpassing the estimated -$0.97 by +22.68%.
Earnings released on 8 Dec 2022
EPS came in at -$0.90 surpassing the estimated -$1.04 by +13.46%.
Earnings released on 8 Sept 2022
EPS came in at -$0.94 surpassing the estimated -$1.02 by +7.84%.
Earnings released on 7 Jul 2022
EPS came in at -$0.98 surpassing the estimated -$1.06 by +7.55%.
Earnings released on 10 Mar 2022
EPS came in at -$0.92 falling short of the estimated -$0.91 by -1.10%.
Earnings released on 9 Dec 2021
EPS came in at -$0.80 falling short of the estimated -$0.78 by -2.56%.
Earnings released on 9 Sept 2021
EPS came in at -$0.66 surpassing the estimated -$0.73 by +9.59%.
Earnings released on 13 Jul 2021
EPS came in at -$0.65 falling short of the estimated -$0.61 by -6.56%, while revenue for the quarter reached $12.69M , beating expectations by +2.09K%.
Earnings released on 11 Mar 2021
EPS came in at -$0.56 surpassing the estimated -$0.60 by +6.67%.
Earnings released on 10 Dec 2020
EPS came in at -$0.58 surpassing the estimated -$0.70 by +17.14%.
Earnings released on 14 Sept 2020
EPS came in at -$0.61 falling short of the estimated -$0.60 by -1.67%.
KALV Stock Performance
Access detailed KALV performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.